Smart Catheter: A Novel Biosensor for Early Detection of Catheter Associated Urinary Tract Infection
1 other identifier
interventional
100
1 country
1
Brief Summary
Urinary Tract Infection (UTI) is the most common hospital acquired infection worldwide, and is most commonly associated with catheterisation of the bladder. Catheter associated urinary tract infection (CAUTI) causes increased hospital costs, increased length of stay and increased mortality. This burden of disease is, in part, mediated by a lack of diagnostic and monitoring modalities for CAUTI. Both traditional and novel UTI diagnostic tests are susceptible to false positives associated with bacterial colonisation, and correlate poorly with clinically meaningful symptomatic CAUTI. As such, the current standard of care is reliant on clinical monitoring, which is susceptible to diagnostic delays, over and under treatment. Imperial College London have developed a wireless biosensor for continuous monitoring of catheter-urine biochemistry. This project aims to validate this biosensor and demonstrate it's potential for preemptive CAUTI diagnosis through continuous urinary biochemical monitoring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2018
CompletedFirst Submitted
Initial submission to the registry
March 18, 2020
CompletedFirst Posted
Study publicly available on registry
March 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2021
CompletedSeptember 2, 2021
September 1, 2021
3.3 years
March 18, 2020
September 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time difference of diagnosis
The time difference of biosensor diagnosis of catheter associated UTI as compared to clinical diagnosis (defined as the prescription time of new antimicrobials for suspected UTI)
From the time of catheterisation, until 72hours post-removal of catheters.
Secondary Outcomes (4)
Sensitivity
From the time of catheterisation, until 72hours post-removal of catheters.
Specificity
From the time of catheterisation, until 72hours post-removal of catheters.
False Positive Rate
From the time of catheterisation, until 72hours post-removal of catheters.
False Negative Rate
From the time of catheterisation, until 72hours post-removal of catheters.
Study Arms (1)
Single arm
OTHERA single arm will have biosensor (experimental) diagnoses compared to clinical (control, current standard of care). All participants in this group willl have a biosensor, with the data masked to patients, providers and clinical researchers
Interventions
A novel biosensor in-built into the catheter drainage system that monitors the chemical composition of the urine, with the intention of providing early diagnosis of developing infection
Eligibility Criteria
You may not qualify if:
- Consent to participate not given Known sensitivity to urinary catheters or electronic products Patients undergoing urologic procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St Mary's Hospital
London, Greater LOndon, W21Y, United Kingdom
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- The biosensors will monitor for infections. As this is an unverified, experimental diagnosis, this will not be made available to the patient or care provider. similarly this will not be available to the clinical researchers in order to avoid observation bias. While the participants, providers and investigators will all be aware that the participants have an active biosensor, they will be blinded to the output thereof.
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 18, 2020
First Posted
March 19, 2020
Study Start
April 1, 2018
Primary Completion
July 31, 2021
Study Completion
July 31, 2021
Last Updated
September 2, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share
Participant Data is confidential and will to be shared